Siemens (NYSE:SI) unveiled a massive reorganization today that could be the 1st step toward a spinout for its healthcare business, which posted 19% profit growth during Siemens’ fiscal 2nd quarter.
Wall Street Beat
CareFusion ChloraPrep sales make a resurgence following kickbacks scandal
California-based CareFusion (NYSE:CFN) posted a strong 3rd quarter and narrowed its full-year sales outlook, touting strong sales growth, even for its controversial ChloraPrep surgical wipes.
Pershing to Allergan: Take the deal
Morgan Stanley: Medtech underperformed in April
The medical device sector under-performed the S&P 500 index in April after a sharp swing over-performance during the 1st quarter, according to analysts at Morgan Stanley.
The 30 medtech stocks Morgan Stanley covers collectively under-performed the S&P by 4.1%, after besting the index by 4.9% during the 1st quarter.
Volcano adds 20 to U.S. sales force
Intuitive Surgical to buy back $1B in shares from Goldman Sachs
Globus Medical posts a strong 1st quarter following robotic surgery entry
Globus Medical (NYSE:GMED) got some Wall Street love after reporting a strong 1st quarter, during which the company notched the acquisition of Excelsius Surgical.
Haemonetics closes Scotland plant, launches $100M buyback after dim quarter
Massachusetts-based Haemonetics (NYSE:HAE) is making some big moves after posting a tough 4th quarter and projecting a dim outlook for the fiscal year ahead.
Teleflex plans layoffs, plant closures in response to ‘cost pressures’
Weight loss: GI Dynamics raises $32M with private placement
GI Dynamics (ASX:GID) said it raised about $31.7 million (A$34.3 million) in a private placement with a group of "sophisticated, professional and accredited investors" overseas.